EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

Current Practice, Safety and Efficacy of Interventions for Recurrent Respiratory Papillomatosis: Evidence From a UK Registry

Adam J Donne, Kim Keltie iD, Julie Burn iD, Emma Belilios, Steven Powell, Paola Cognigni, Iain J Nixon, Neil Bateman, Haytham Kubba, Owen Judd, Andrew Sims iD

Clinical Otolaryngology · 2025-03 · 50 (2) · 271-279

DOI: 10.1111/coa.14245 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Otolaryngology, online erschienen am 24.10.2024. Verfasst von Adam J Donne und 10 weiteren Autor:innen. Beteiligte Einrichtung: Alder Hey Children's NHS Foundation Trust, Liverpool, UK. Hauptthemen laut MEDLINE: Papillomavirus Infections, Respiratory Tract Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Research for Patient Benefit Programme, National Institute for Health Research Clinical Research Network (NIHR CRN).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To determine the current practice, safety and efficacy of interventions used in the management of recurrent respiratory papillomatosis (RRP) in the UK NHS.

Design

Prospective registry (recruitment between 1st April 2018 and 31st August 2022, retrospective data from 1st January 2015 permitted with consent). Sub‐group data‐linked to Hospital Episode Statistics for additional follow‐up (until 31st July 2022).

Setting

UK NHS hospitals treating RRP patients.

Participants

Children and adults diagnosed with RRP and managed in an NHS hospital. Main Outcome Measures Disease severity (Derkay, voice handicap and GRBAS scores), management (type and frequency of surgical and adjuvant intervention) and complications (cancer, death).

Results

Three hundred and thirty patients were entered into the registry; 304 (including 65 children) were eligible for analysis. Children had more severe disease than adults (median Derkay score 10 vs. 5). Microdebrider was the most common surgical intervention, particularly in children (86% of children, 49% of adults). Additionally, lasers (CO 2 , KTP and pulsed dye) were used in 34% of adults. Gardasil was the most common adjuvant therapy (21 children, 23 adults). Procedural complications were rare (10.8% children, 5.9% adults). Five patients developed laryngeal malignancy; there were six deaths during follow‐up period.

Conclusions

This is the largest UK RRP study to date. RRP is more aggressive in children than adults, and treatment choice differs between age groups. Overall, management was safe with minimal complications reported, and generally effective in maintaining a safe airway. Standardised reporting is required to objectively monitor disease progression and safety over time. Trial Registration: NCT03465280, ISRCTN36100560

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsRespiratory Tract InfectionsAdolescentAdultAgedChildChild, PreschoolFemaleHumansInfantMaleMiddle AgedYoung AdultProspective StudiesRegistriesRetrospective StudiesTreatment OutcomeUnited Kingdom

Stichwörter der Autor:innen

health information systemspatient safetytreatment outcome

Autor:innen und Institutionen

  • Alder Hey Children's NHS Foundation Trust, Liverpool, UK.
  • The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
  • Translational and Clinical Research Institute, Faculty of Medical Sciences, University of Newcastle upon Tyne, Newcastle upon Tyne, UK.
  • Population Health Sciences Institute, Faculty of Medical Sciences, University of Newcastle upon Tyne, Newcastle upon Tyne, UK.
  • Department of Otolaryngology Head and Neck Surgery, NHS Lothian, Edinburgh, UK.
  • Royal Manchester Children's Hospital, Manchester, UK.

ORCID-Profile: Kim Keltie, Julie Burn, Andrew Sims

Förderung

  • Research for Patient Benefit Programme
  • National Institute for Health Research Clinical Research Network (NIHR CRN)

Zitieren

APA

Donne, A. J., Keltie, K., Burn, J., Belilios, E., Powell, S., Cognigni, P., Nixon, I. J., Bateman, N., Kubba, H., Judd, O., & Sims, A. (2025). Current Practice, Safety and Efficacy of Interventions for Recurrent Respiratory Papillomatosis: Evidence From a UK Registry. Clinical Otolaryngology, 50(2), 271-279. https://doi.org/10.1111/coa.14245

Vancouver

Donne AJ, Keltie K, Burn J, Belilios E, Powell S, Cognigni P, et al. Current Practice, Safety and Efficacy of Interventions for Recurrent Respiratory Papillomatosis: Evidence From a UK Registry. Clinical Otolaryngology. 2025;50(2):271-279. doi:10.1111/coa.14245

BibTeX
@article{Donne2025,
  author = {Donne, Adam J and Keltie, Kim and Burn, Julie and Belilios, Emma and Powell, Steven and Cognigni, Paola and Nixon, Iain J and Bateman, Neil and Kubba, Haytham and Judd, Owen and Sims, Andrew},
  title = {Current Practice, Safety and Efficacy of Interventions for Recurrent Respiratory Papillomatosis: Evidence From a UK Registry},
  journal = {Clinical Otolaryngology},
  year = {2025},
  volume = {50},
  number = {2},
  pages = {271--279},
  doi = {10.1111/coa.14245}
}
Kostenlos starten →